LRIG2 and oligodendroglioma: Increased LRIG2 expression correlates with a poorer prognosis in patients with oligodendroglioma (Holmlund et al., 2009), cervical SCC (Hedman et al., 2010), non‐small cell lung cancer (Wang et al., 2014), and glioblastoma (Wang et al., 2009).